Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.

HIV medicine - 1 Oct 2018

Rossetti B, Di Giambenedetto S, Torti C, Postorino M C, Punzi G, Saladini F, Gennari W, Borghi V, Monno L, Pignataro A R, Polilli E, Colafigli M, Poggi A, Tini S, Zazzi M, De Luca A

Abstract excerpt

OBJECTIVES: The aim was to evaluate the evolution of transmitted HIV-1 drug resistance (TDR) prevalence in antiretroviral therapy (ART)-naïve patients from 2006 to 2016. METHODS: HIV-1 sequences were retrieved from the Antiviral Response Cohort Analysis (ARCA) database and TDR was defined as detection of at least one mutation from the World Health Organization (WHO) surveillance list. RESULTS: We included...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Odds Ratio

Share to Viral Proteins

Source

Identifiers

PMID: 29932313
DOI: 10.1111/hiv.12640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.PMID 29932313Read ↗

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.Semantic proximity Read ↗

HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.Semantic proximity Read ↗

Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experienceSemantic proximity Read ↗

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.Semantic proximity Read ↗

Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024.Semantic proximity Read ↗

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.Semantic proximity Read ↗

Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis.Semantic proximity Read ↗

Marked decrease in acquired resistance to antiretrovirals in latest years in Italy.Semantic proximity Read ↗

Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017-2023.Semantic proximity Read ↗

Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.Semantic proximity Read ↗

HIV MDR is still a relevant issue despite its dramatic drop over the years.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.